Your browser doesn't support javascript.
COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.
Dhama, Kuldeep; Sharun, Khan; Tiwari, Ruchi; Dhawan, Manish; Emran, Talha Bin; Rabaan, Ali A; Alhumaid, Saad.
  • Dhama K; Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.
  • Sharun K; Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, India.
  • Tiwari R; Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, India.
  • Dhawan M; Department of Microbiology, Punjab Agricultural University, Ludhiana, India.
  • Emran TB; The Trafford Group of Colleges, Manchester, UK.
  • Rabaan AA; Department of Pharmacy, BGC Trust University Bangladesh, Chittagong, Bangladesh.
  • Alhumaid S; Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Hum Vaccin Immunother ; 17(10): 3495-3499, 2021 Oct 03.
Artículo en Inglés | MEDLINE | ID: covidwho-1287958
ABSTRACT
The ongoing coronavirus disease (COVID-19) vaccination drive aims to achieve global vaccination coverage that will help to control the pandemic. Therefore, the individuals who are reluctant to be vaccinated or forego COVID-19 vaccination can delay the progress of overall vaccination coverage, leading to slower vaccination rates and may create obstacles in global efforts to control the circulation of SARS-CoV-2 as unvaccinated individuals can act as reservoirs of SARS-CoV-2 and could drive further outbreaks. Vaccine hesitancy is one of the major threats that directly impact global health as it challenges our ability to eradicate infectious diseases and achieve significant herd immunity through vaccination. One of the strategies to counter vaccine hesitancy is to follow a multisectoral approach that involves the collaboration between various stakeholders, such as government, private companies, religious groups, and other agencies, to leverage the knowledge, expertise, and resources, thereby enabling the creation of longstanding public trust of vaccines.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Estudio experimental / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Hum Vaccin Immunother Año: 2021 Tipo del documento: Artículo País de afiliación: 21645515.2021.1926183

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Estudio experimental / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos Idioma: Inglés Revista: Hum Vaccin Immunother Año: 2021 Tipo del documento: Artículo País de afiliación: 21645515.2021.1926183